BioShin
Develop and sell a series of Biohaven pharmaceutical products in Asia.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD327—491m (Dealroom.co estimates Sep 2020.)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$60.0m | Series A | ||
| Total Funding | CAD81.8m | ||
Related Content
Recent News about BioShin
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.